Nanoparticles deliver small interfering RNA to slow multiple myeloma
Research led by the University of Pennsylvania, Philadelphia, has used siRNA-based silencing of protein cyclophilin A (CyPA) to reduce tumor burden and extend the lives of patients with multiple myeloma. In the paper, "In vivo bone marrow microenvironment siRNA delivery using lipid–polymer nanoparticles for multiple myeloma therapy," published in PNAS, the researchers detail a targeted nanoparticle platform [...]









